EW - Edwards Lifesciences Corporation

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 530.45B
Enterprise Value 330.91B
Trailing P/E 47.76
Forward P/E 127.80
PEG Ratio (5 yr expected) 12.80
Price/Sales (ttm)8.58
Price/Book (mrq)9.61
Enterprise Value/Revenue 38.71
Enterprise Value/EBITDA 628.81

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Jun 30, 2018

Profitability

Profit Margin 18.50%
Operating Margin (ttm)27.98%

Management Effectiveness

Return on Assets (ttm)11.47%
Return on Equity (ttm)21.51%

Income Statement

Revenue (ttm)3.55B
Revenue Per Share (ttm)16.86
Quarterly Revenue Growth (yoy)12.10%
Gross Profit (ttm)2.56B
EBITDA 1.07B
Net Income Avi to Common (ttm)656.6M
Diluted EPS (ttm)3.05
Quarterly Earnings Growth (yoy)51.90%

Balance Sheet

Total Cash (mrq)1.4B
Total Cash Per Share (mrq)6.69
Total Debt (mrq)1.19B
Total Debt/Equity (mrq)37.71
Current Ratio (mrq)2.28
Book Value Per Share (mrq)15.12

Cash Flow Statement

Operating Cash Flow (ttm)966.2M
Levered Free Cash Flow (ttm)440.98M

Trading Information

Stock Price History

Beta (3Y Monthly) 0.53
52-Week Change 329.10%
S&P500 52-Week Change 37.95%
52 Week High 3175.00
52 Week Low 3100.20
50-Day Moving Average 3150.63
200-Day Moving Average 3144.05

Share Statistics

Avg Vol (3 month) 31.56M
Avg Vol (10 day) 32.29M
Shares Outstanding 5209.39M
Float 207.8M
% Held by Insiders 13.94%
% Held by Institutions 10.00%
Shares Short (Sep 28, 2018) 43.61M
Short Ratio (Sep 28, 2018) 42.56
Short % of Float (Sep 28, 2018) 41.92%
Short % of Shares Outstanding (Sep 28, 2018) 41.72%
Shares Short (prior month Aug 31, 2018) 42.38M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 22/1
Last Split Date 3Dec 14, 2015